Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Coleman Website

C. Norman Coleman, M.D.

Selected Publications

1)  Coleman CN.
Fukushima and the future of radiation research.
Radiat. Res. 179: 1-8, 2013.
2)  Lawrence YR, Vikram B, Dignam JJ, Chakravarti A, Machtay M, Freidlin B, Takebe N, Curran WJ, Bentzen SM, Okunieff P, Coleman CN, Dicker AP.
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
J. Natl. Cancer Inst. 105: 11-24, 2013.
3)  Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, Guha C, Krishnan S, Lawrence TS, Le Q, Lu B, Mehta M, Peereboom D, Sarkaria J, Seong J, Wang D, Welliver MX, Coleman CN, Vikram B, Yoo S, Chung CH.
Opportunities and Challenges in the Era of Molecularly Targeted Agents and Radiation Therapy.
J. Natl. Cancer Inst. [Epub ahead of print], 2013.
4)  Makinde AY, John-Aryankalayil M, Palayoor ST, Cerna D, Coleman CN.
Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy.
Mol. Cancer Res. 11: 5-12, 2013.
5)  Coleman CN, Whitcomb RC, Miller CW, Noska MA.
Commentary on the combined disaster in Japan.
Radiat. Res. 177: 15-7, 2012.
6)  Coleman CN, Lurie N.
Emergency medical preparedness for radiological/nuclear incidents in the United States.
J Radiol Prot. 32: N27-32, 2012.
7)  John-Aryankalayil M, Palayoor ST, Makinde AY, Cerna D, Simone CB, Falduto MT, Magnuson SR, Coleman CN.
Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells.
Radiat Res. [Epub ahead of print], 2012.
8)  Palayoor ST, J-Aryankalayil M, Makinde AY, Cerna D, Falduto MT, Magnuson SR, Coleman CN.
Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.
J. Cardiovasc. Pharmacol. 59: 487-99, 2012.
9)  Cerna D, Li H, Flaherty S, Takebe N, Coleman CN, Yoo SS.
Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) activity by the small molecule GMX1778 regulates ROS-mediated cytotoxicity in a p53- and Nicotinic Acid Phosphoribosyltransferase1 (NAPRT1)-dependent manner.
J Biol Chem. [Epub ahead of print], 2012.
10)  Coleman CN, Adams S, Adrianopoli C, Ansari A, Bader JL, Buddemeier B, Caro JJ, Casagrande R, Case C, Caspary K, Chang AS, Chang HF, Chao N, Cliffer KD, Confer D, Deitchman S, Derenzo EG, Dobbs A, Dodgen D, Donnelly EH, Gorman S, Grace MB, Hatchett R, Hick JL, Hrdina C, Jones R, Kane E, Knebel A, Koerner JF, Laffan AM, Larson L, Livinski A, Mackinney J, Maidment BW, Manning R, Marinissen MJ, Martin C, Michael G, Murrain-Hill P, Nemhauser JB, Norwood AE, Nystrom S, Raheem M, Redlener I, Sheehan K, Simon SL, Taylor TP, Toner E, Wallace KS, Wieder J, Weinstock DM, Wiley AL, Yeskey K.
Medical planning and response for a nuclear detonation: a practical guide.
Biosecur Bioterror. 10: 346-71, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 4/8/2013.